emgality solution
eli lilly canada inc - galcanezumab - solution - 120mg - galcanezumab 120mg - calcitonin-gene-related peptide (cgrp) antagonists
emgality solution
eli lilly canada inc - galcanezumab - solution - 120mg - galcanezumab 120mg - calcitonin-gene-related peptide (cgrp) antagonists
emgality solution for injection in pre-filled syringe 100 mgml
dksh singapore pte. ltd. - galcanezumab - injection, solution - galcanezumab 100 mg/ml
emgality solution
eli lilly canada inc - galcanezumab - solution - 100mg - galcanezumab 100mg - calcitonin-gene-related peptide (cgrp) antagonists
emgality
eli lilly nederland b.v. - galcanezumab - migraine disorders - analgesics, galcanezumab - emgality is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
emgality 120 mg
eli lilly israel ltd, israel - galcanezumab - solution for injection - galcanezumab 120 mg / 1 ml - galcanezumab - emgality is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
emgality
eli lilly and company (nz) limited - galcanezumab 120 mg/ml - solution for injection - 120 mg/ml - active: galcanezumab 120 mg/ml excipient: histidine histidine hydrochloride monohydrate polysorbate 80 sodium chloride water for injection - emgality is indicated for the prophylaxis of migraine in adults
emgality
eli lilly and company (nz) limited - galcanezumab 120 mg/ml - solution for injection - 120 mg/ml - active: galcanezumab 120 mg/ml excipient: histidine histidine hydrochloride monohydrate polysorbate 80 sodium chloride water for injection - emgality is indicated for the prophylaxis of migraine in adults
pontevia 120 mg solution for injection in pre-filled syringe
zuellig pharma sdn bhd - galcanezumab -
pontevia 120 mg solution for injection in pre-filled pen
zuellig pharma sdn bhd - galcanezumab -